H. Manzano
发表
Prospective Biomarker Study in Advanced RAS Wild‐Type Colorectal Cancer: POSIBA Trial (GEMCAD 10‐02)
F. Rojo,
J. Feliu,
J. Maurel,
2019,
The oncologist.
I. Durán,
J. Rifá,
R. Pazo,
2004,
Journal of Neuro-Oncology.
I. Chirivella,
R. Salazar,
C. Conill,
2005,
International journal of radiation oncology, biology, physics.
J. Aparicio,
A. Ruiz-Casado,
A. Férnández-Montes,
2020,
Journal of clinical medicine.
A. Carrato,
R. Salazar,
C. García-Girón,
2021,
Drugs & Aging.
F. Rojo,
J. Feliu,
J. Maurel,
2018,
Neoplasia.
F. Rojo,
B. Bellosillo,
C. Montagut,
2019,
JCO precision oncology.
M. Rubini,
J. Aparicio,
J. Feliu,
2016
.
F. Rojo,
J. Feliu,
M. Cuatrecasas,
2016
.
A. Carrato,
J. Tabernero,
J. García-Foncillas,
2012,
PloS one.
Á. Arcusa,
L. Cirera,
P. Escudero,
2005,
European journal of cancer.
Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer
R. Magallón,
S. Pita-Fernández,
M. Sanchez,
2013,
BMC Cancer.
A. Pazos,
F. Macià,
M. Esteva,
2010,
BMC Cancer.
Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer
R. Magallón,
S. Pita-Fernández,
F. Macià,
2013,
BMC Cancer.
Á. Arcusa,
H. Manzano,
F. Losa,
2004,
Anti-cancer drugs.